<DOC>
	<DOCNO>NCT01327391</DOCNO>
	<brief_summary>The aim study appreciate tolerance `` line '' hemodiafiltration impact morbidity cardiovascular risk factor chronic renal failure patient .</brief_summary>
	<brief_title>Tolerance `` Line '' Hemodiafiltration Chronic Renal Failure Patients</brief_title>
	<detailed_description>The aim study appreciate tolerance `` line '' HDF treatment versus conventional high flux hemodialysis term adverse event occur dialysis session day 30 day 120 treatment evaluate : - Quality life evaluate KDQOL questionnaire - Incidence cardiovascular event - Influence technic cardiovascular , inflammatory infectious risk factor - Mortality</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>Patient sign write consent form Patient age &gt; 65 &lt; 90 year With creatinine clearance &lt; 10 mL/min On dialysis minimum 3 month , 3 time week hemodialysis session Erythropoietin dosage need maintain hemoglobin constant level ( range hemoglobin : 913 g/dL without variation 2g/dL less 3 month ) Without problem vascular access Patient age &lt; 65 &gt; 90 year Presence severe malnutrition ( albumin &lt; 20 g/L ) Unstable clinical condition Unipuncture fail vascular access flow Known problem coagulation</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>line hemodiafiltration</keyword>
	<keyword>tolerance</keyword>
	<keyword>quality life</keyword>
	<keyword>cardiovascular risk</keyword>
	<keyword>Hemodialysis patient</keyword>
</DOC>